S&P Announces Changes to US Index: SVR for EYE
More News related to ABT
- Abbott (ABT) sues Teva (TEVA) over its drug for kidney patients, Zemplar
- The Deal Names Abbott Top Dealmaker for Second Consecutive Year
- Hilliard Lyons Downgrades Abbott Labs (ABT) to Long-Term Buy
- Abbott to Develop New Heart Failure Test on ARCHITECT(R) Immunochemistry Diagnostics Platform
- Morgan Joseph Initiates Coverage on Boston Scientific (BSX) with a Hold; Shares Fully Valued
More News related to EYE
- Advanced Medical Optics (EYE) Tops Q4 Views
- S&P Announces Changes to US Index: SVR for EYE
- Top 10 News Items 1/12-1/16: BofA Gets More Federal Aid, Reports Q4 Loss, Cuts Dividend; Job's to Take Medical Leave; Citi and Morgan Stanley Combine Brokerage Units
- Unusual 11 Mid-Day Movers 1/12: EYE, ETRM, HOLX, VOXX Higher; SAY, LNY, RUTH, ALD Lower
- Morning Movers 1/12: Advanced Medical Optics (EYE) Surges On Buyout; Harley-Davidson (HOG) Lower on Downgrade
More News related to SVR
- Syniverse Renews Pact with Cellular South, Builds on Success in North America
- Syniverse Provides Array of Services to 100 Operators in Asia Pacific
- Syniverse Executive Named to Open Mobile Alliance Board
- VIVA Appoints Syniverse to Optimize Roaming and Messaging Service Delivery
- Syniverse to Present at Stephens Inc. Fall Investment Conference
More News related to Corporate News
- Highlights From MDT's Q3 Conference Call: U.S. Revenues up 5%, International Sales Up 13%; Guides Above for FY10
- Highlights From HNZ's Q2 Conference Call: Continued Growth Overseas; Guides Higher for FY10
- Radient Pharma (RPC) Posts Q3 Loss of $0.31, Wider Y/Y; Revs Lower
- Brocade (BRCD) Q4 Sales Jump, CEO Forced To Address Rumors
- Highlights From Brocade Communications's (BRCD) Q4 Q&A Session; Reaffirms FY10 Outlook
Syniverse Holdings Inc. (NYSE: SVR) will replace Advanced Medical Optics Inc. (NYSE: EYE) in the S&P MidCap 400 after the close of trading on a date to be announced. Advanced Medical Optics is being acquired by S&P 100 and 500 constituent Abbott Laboratories (NYSE: ABT) in a cash tender offer that is still pending final approvals.
Related Categories
Corporate NewsHot List
Trader Talk
Stocks Mentioned
+1.17
-0.19Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
